A European study on acetate free biofiltration versus bicarbonate dialysis (quality control)

Hospal S.p.A. (Italy)0 个研究点目标入组 400 人开始时间: 2006年7月3日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•All new patients (who started haemodialysis up to ten months prior to the start of the protocol) defined as ?critical? will be included in the study after an adequate information about the aims of the study.
•Critical patients are defined as such if they present at least one of the following conditions:
•1. Diabetes
•2. Age equal or over 60 years
•3. Cardiovascular instability (defined as a frequency of hypotensive episodes in more than 20% of dialysis sessions, or independently of frequency, if hypotension is accompanied by angina or major arrhythmia's)

•1. Age greater than 78 years
•2. Active neoplasia
•3. Severe cardiopathies (New York Heart Association [NYHA] Class III & Class IV)
•4. Decompensating cirrhosis
•5. Poor vascular access function (pump flow (Qb) less than 200 ml/m or need for single needle system)
•6. Previous continuous ambulatory peritoneal dialysis (CAPD) treatment or kidney transplant
•7. On waiting list for kidney transplant

发起方

Hospal S.p.A. (Italy)